# Assessing the Efficacy and Safety of Metformin in Treatment of Moderate Psoriasis

> **NCT02644954** · PHASE3 · UNKNOWN · sponsor: **Post Graduate Institute of Medical Education and Research, Chandigarh** · enrollment: 40 (estimated)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Metformin
- **DRUG:** Placebo
- **DRUG:** Topical Coal tar
- **DRUG:** Topical calcipotriol

## Key facts

- **NCT ID:** NCT02644954
- **Lead sponsor:** Post Graduate Institute of Medical Education and Research, Chandigarh
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2016-06
- **Final completion:** —
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2016-01-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02644954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02644954, "Assessing the Efficacy and Safety of Metformin in Treatment of Moderate Psoriasis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02644954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*